GeneDx to Participate in Fall Investor Conferences

Article Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 7/14/2026

1. USO
2. SPY
3. AAPL
4. JPM
5. NFLX

6. QTTB
7. ERAS
8. PSKY
9. BIIB
10. SPRO

Get Alerts WGS Hot Sheet

Price: $63.85 --0%

Overall Analyst Rating:
SELL (= Flat)

EPS Growth %: -128.0%

Join SI Premium – FREE

STAMFORD, Conn.--(BUSINESS WIRE)-- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences this fall:

UBS Genomic Medicine Summit – August 13-14, 2024
Dana Point, California
Future of Genetic Testing - Babies and Beyond Panel on Wednesday, August 14 at 8:00 a.m. PT
Morgan Stanley Healthcare Conference - September 4-6, 2024
New York, New York
Wells Fargo Healthcare Conference - September 4-6, 2024
Boston, Massachusetts
Fireside chat on Thursday, September 5 at 8:45 a.m. ET
Jefferies London Healthcare Conference - November 19-21, 2024
London, England

Live and archived webcasts of select presentations will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events.

About GeneDx

At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram.